DSF/Cu treatment induces apoptosis in breast cancer cells and releases DAMPs, including calreticulin (CRT), high mobility group box 1 (HMGB1), heat shock protein (HSP) 70, and HSP 90 (Guo et al., 2024). Here, CALR is linked to breast cancer.